Gyrodyne , LLC (NASDAQ:GYRO – Get Free Report) was the target of a large increase in short interest in the month of June. As of June 15th, there was short interest totaling 805 shares, an increase of 400.0% from the May 31st total of 161 shares. Based on an average daily volume of 2,212 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.0% of the company’s stock are short sold.
Hedge Funds Weigh In On Gyrodyne
Institutional investors have recently bought and sold shares of the company. Advisory Services Network LLC bought a new stake in shares of Gyrodyne in the third quarter valued at approximately $77,000. Susquehanna International Group LLP purchased a new stake in shares of Gyrodyne during the 3rd quarter valued at approximately $142,000. Teton Advisors LLC bought a new position in Gyrodyne in the 3rd quarter worth approximately $177,000. Finally, Bulldog Investors LLP bought a new position in Gyrodyne in the 3rd quarter worth approximately $601,000. Hedge funds and other institutional investors own 71.36% of the company’s stock.
Gyrodyne Stock Down 0.1%
Shares of NASDAQ:GYRO traded down $0.00 during mid-day trading on Friday, hitting $6.13. 139 shares of the company traded hands, compared to its average volume of 1,640. Gyrodyne has a 12-month low of $6.00 and a 12-month high of $12.00. The stock has a 50-day moving average price of $6.95 and a two-hundred day moving average price of $8.10.
Gyrodyne Company Profile
Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.
The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.
Further Reading
- Five stocks we like better than Gyrodyne
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
Receive News & Ratings for Gyrodyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyrodyne and related companies with MarketBeat.com's FREE daily email newsletter.
